Yingying Du

Statistics

Publications

Citations

116

H-Index

Active since

2011

Affiliations

First Affiliated Hospital of Anhui Medical University(Current)

Anhui Medical University

Guangdong Provincial People's Hospital

Guangdong Academy of Medical Sciences

Yingying Du is an author at First Affiliated Hospital of Anhui Medical University specializing in medicine, oncology, and non-small cell lung cancer therapy.

ORCID

Publications per year

2011–2021

Publications

Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050)

Ying Cheng, Tony Mok, Xiangdong Zhou et al. · Lung Cancer · 2021 · 42 citations · Full text

Medicine, Oncology, Pharmacology +11

Prognostic role of LSD1 in various cancers: evidence from a meta-analysis

Yueyin Pan, Jin Wu, Lixia Hu et al. · OncoTargets and Therapy · 2015 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +10

Study of efficacy and safety of pulsatile administration of high‐dose gefitinib or erlotinib for advanced non‐small cell lung cancer patients with secondary drug resistance: <scp>A</scp> single center, single arm, phase <scp>II</scp> clinical trial

Yanzhe Zhu, Yingying Du, Hu Liu et al. · Thoracic Cancer · 2016 · 21 citations · Full text

Medicine, Oncology, Pharmacology +14

Effects of Tissue Factor Pathway Inhibitor-2 Expression on Biological Behavior of BeWo and JEG-3 Cell Lines

Qiongjie Zhou, Yu Xiong, Yan Chen et al. · Clinical and Applied Thrombosis/Hemostasis · 2011 · 15 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Unexpected favorable outcome to sintilimab plus bevacizumab in an <scp><i>EGFR</i></scp>‐mutated non‐small cell lung cancer patient: A case report

Yiruo Zhang, Mei Zhao, Shuliang Cao et al. · Thoracic Cancer · 2020 · 10 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–5 of 5